Published in J Exp Med on February 01, 1973
The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med (1976) 7.57
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol (1992) 5.04
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 5.02
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol (1982) 4.08
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest (1982) 3.49
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg (1977) 3.02
Polymorphonulcear leukocyte chemotaxis toward oxidized lipid components of cell membranes. J Exp Med (1975) 2.91
Motility and adhesiveness in human neutrophils. Effects of chemotactic factors. J Clin Invest (1979) 2.91
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Sensory adaptation of leukocytes to chemotactic peptides. J Cell Biol (1979) 2.61
Role of secretory events in modulating human neutrophil chemotaxis. J Clin Invest (1978) 2.59
Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J Clin Invest (1984) 2.57
Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization. J Clin Invest (1980) 2.50
Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest (1989) 2.50
Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest (1991) 2.50
The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 2.45
Functional activity of enucleated human polymorphonuclear leukocytes. J Cell Biol (1983) 2.32
Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol (2008) 2.32
Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A (1986) 2.28
Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes. J Clin Invest (1977) 2.24
Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation. J Cell Biol (1999) 2.11
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin. J Cell Biol (1983) 2.07
Acute inflammation. A review. Am J Pathol (1977) 2.06
Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 2.04
Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med (1982) 2.04
Leucoattractants enhance complement receptors on human phagocytic cells. Clin Exp Immunol (1979) 2.04
Use of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease. J Clin Invest (1980) 1.97
Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J Cell Biol (1984) 1.95
Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut (1992) 1.94
Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes. Am J Pathol (1978) 1.91
Some interrelations of neutrophil chemotaxis, lysosomal enzyme secretion, and phagocytosis as revealed by synthetic peptides. Am J Pathol (1976) 1.86
Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest (1989) 1.86
PDGF alpha- and beta-receptors activate unique and common signal transduction pathways. EMBO J (1992) 1.85
Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med (1995) 1.80
Mesenchymal chemotaxis requires selective inactivation of myosin II at the leading edge via a noncanonical PLCγ/PKCα pathway. Dev Cell (2014) 1.79
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest (1985) 1.79
The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest (1995) 1.73
In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res (2007) 1.71
Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants. J Clin Invest (1981) 1.65
Enhancement of neutrophils function as a result of prior exposure to chemotactic factor. J Clin Invest (1980) 1.64
Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J Clin Invest (1989) 1.62
B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. Proc Natl Acad Sci U S A (1990) 1.60
Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest (1990) 1.59
Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipocytes. Proc Natl Acad Sci U S A (1982) 1.58
CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (1991) 1.58
Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit. J Exp Med (1981) 1.57
Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol (1985) 1.56
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
A proposal for the definition of terms related to locomotion of leucocytes and other cells. Clin Exp Immunol (1977) 1.55
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun (1980) 1.48
IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology (1990) 1.47
Release of a potent polymorphonuclear leukocyte chemoattractant is regulated by white-opaque switching in Candida albicans. Infect Immun (2004) 1.46
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest (1990) 1.46
Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells (2008) 1.46
Evaluation of leukocyte chemotaxis in vitro in thermally injured patients. J Clin Invest (1974) 1.45
Antigen-induced locomotor responses in lymphocytes. J Exp Med (1977) 1.42
Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest (1986) 1.41
Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest (1988) 1.41
Transepithelial chemotaxis of rat peritoneal exudate cells. Br J Exp Pathol (1983) 1.40
Chemotropism indices for polymorphonuclear leukocytes. Biophys J (1976) 1.40
Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes. Clin Exp Immunol (1986) 1.40
Therapeutic approaches to anergy in surgical patients. Surgery and levamisole. Ann Surg (1979) 1.39
Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1979) 1.39
Chemotaxis of mitogen-activated human lymphocytes and the effects of membrane-active enzymes. Clin Exp Immunol (1976) 1.39
Myosin II is essential for the spatiotemporal organization of traction forces during cell motility. Mol Biol Cell (2009) 1.37
Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. Immunology (1987) 1.37
Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A (1992) 1.36
Lymphocyte migration into three-dimensional collagen matrices: a quantitative study. J Cell Biol (1983) 1.35
The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis. Br J Pharmacol (1980) 1.33
Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinases. J Exp Med (1987) 1.32
Leukotaxis and leukotactic disorders. A review. Am J Pathol (1974) 1.31
Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut (1981) 1.31
A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus. J Clin Invest (1978) 1.28
A lipid chemotactic factor from anaerobic coryneform bacteria including Corynebacterium parvum with activity for macrophages and monocytes. Immunology (1976) 1.27
Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]. J Immunol (2010) 1.27
Chemotactic activity in dialyzable transfer factor. Proc Natl Acad Sci U S A (1974) 1.26
Generation of a fibroblast chemotactic factor in serum by activation of complement. J Clin Invest (1979) 1.26
Human eosinophils express functional interleukin 2 receptors. J Clin Invest (1991) 1.26
Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering. Tissue Eng Part B Rev (2008) 1.24
Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid. Br J Pharmacol (1988) 1.23
Effects of levamisole on normal and abnormal leukocyte locomotion. J Clin Invest (1977) 1.23
Effects of fever on host defense mechanisms after infection in the lizard Dipsosaurus dorsalis. Br J Exp Pathol (1978) 1.22
Characterization of a class of nonformylated Enterococcus faecalis-derived neutrophil chemotactic peptides: the sex pheromones. Proc Natl Acad Sci U S A (1990) 1.22
Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J (2004) 1.21
Comparison of leukocyte count and function in smoking and nonsmoking young men. Infect Immun (1975) 1.21
Thrombospondin stimulates motility of human neutrophils. J Cell Biol (1990) 1.20
Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun (1982) 1.19
Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine. J Exp Med (1995) 1.19
Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. Am J Pathol (1984) 1.19
Localization of submembranous cations to the leading end of human neutrophils during chemotaxis. J Cell Biol (1979) 1.18
Adenosine promotes neutrophil chemotaxis. J Exp Med (1988) 1.18
Laminin promotes rabbit neutrophil motility and attachment. J Clin Invest (1986) 1.17
Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line. Proc Natl Acad Sci U S A (1980) 1.17
Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome. Ann Rheum Dis (1981) 1.15
The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med (1962) 23.03
Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J Exp Med (1956) 14.38
Role of chemotaxis in inflammation. Physiol Rev (1954) 8.58
The isolation and selected properties of blood monocytes. J Exp Med (1966) 7.78
The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol (1971) 5.76
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med (1972) 3.93
C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol (1970) 3.75
Analysis of individual leucocyte behavior during chemotaxis.. Exp Cell Res (1972) 3.07
Eosinophil cell separation from human peripheral blood. Immunology (1970) 2.70
Re-assessment of Boyden's technique for measuring chemotaxis. J Immunol Methods (1972) 2.05
Chemotaxis of leucocytes and inflammation. Ser Haematol (1970) 2.00
The chemotaxis of polymorphonuclear leucocytes towards damaged tissue. Br J Exp Pathol (1966) 1.84
Immunoglobulin G as possible precursor of chemotactic factor. Nature (1970) 1.82
Studies on chemotaxis. XI. Effect on neutrophils of lysosomal and other subcellular fractions from leukocytes. Int Arch Allergy Appl Immunol (1969) 1.73
Polymorphonuclear leukocyte motility in vitro. 3. Possible release of a chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes. Arthritis Rheum (1969) 1.69
Studies on chemotaxis. Effect of subcellular leukocyte fractions on neutrophils and macrophages. Int Arch Allergy Appl Immunol (1970) 1.52
Ultrastructure of human leukocytes after simultaneous fixation with glutaraldehyde and osmium tetroxide and "postfixation" in uranyl acetate. J Cell Biol (1968) 11.00
The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites. J Exp Med (1972) 8.66
The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med (1976) 7.57
Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J Cell Biol (1977) 7.13
Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Annu Rev Cell Biol (1988) 5.30
The in vitro differentiation of mononuclear phagocytes. V. The formation of macrophage lysosomes. J Exp Med (1966) 4.84
Resolution of granules from rabbit heterophil leukocytes into distinct populations by zonal sedimentation. J Cell Biol (1969) 4.36
Morphology and peroxidase cytochemistry of mouse promonocytes, monocytes, and macrophages. J Exp Med (1970) 4.26
The interaction between Toxoplasma gondii and mammalian cells. I. Mechanism of entry and intracellular fate of the parasite. J Exp Med (1972) 4.26
The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ (1972) 4.25
Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis. Exp Cell Res (1972) 3.95
Assessment in vitro of immunity against Toxoplasma gondii. J Exp Med (1975) 3.50
The in vitro differentiation of mononuclear phagocytes. IV. The ultrastructure of macrophage differentiation in the peritoneal cavity and in culture. J Exp Med (1966) 3.41
Further biochemical and morphological studies of granule fractions from rabbit heterophil leukocytes. J Cell Biol (1970) 3.06
The effects of mercaptoethanol and of peritoneal macrophages on the antibody-forming capacity of nonadherent mouse spleen cells in vitro. J Exp Med (1972) 2.95
The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells. J Exp Med (1971) 2.92
Chemotactic peptide receptor modulation in polymorphonuclear leukocytes. J Cell Biol (1980) 2.72
Cell polarity: an examination of its behavioral expression and its consequences for polymorphonuclear leukocyte chemotaxis. J Cell Biol (1981) 2.64
Sensory adaptation of leukocytes to chemotactic peptides. J Cell Biol (1979) 2.61
Mechanisms of sensing chemical gradients by polymorphonuclear leukocytes. Nature (1974) 2.48
Phagocytosis. Annu Rev Microbiol (1965) 2.35
Chemotaxis by polymorphonuclear leukocytes. J Cell Biol (1978) 2.20
A stochastic model for leukocyte random motility and chemotaxis based on receptor binding fluctuations. J Cell Biol (1988) 2.18
Vesicle fusion and formation at the surface of pinocytic vacuoles in macrophages. J Cell Biol (1968) 2.15
Autophagic vacuoles produced in vitro. I. Studies on cultured macrophages exposed to chloroquine. J Cell Biol (1968) 2.15
Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes. J Cell Biol (1985) 2.08
Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology (2004) 2.04
Kinetic analysis of F-actin depolymerization in polymorphonuclear leukocyte lysates indicates that chemoattractant stimulation increases actin filament number without altering the filament length distribution. J Cell Biol (1991) 1.94
Autophagic vacuoles produced in vitro. II. Studies on the mechanism of formation of autophagic vacuoles produced by chloroquine. J Cell Biol (1968) 1.91
Changes in cytoskeletal proteins of polymorphonuclear leukocytes induced by chemotactic peptides. Cell Motil (1983) 1.90
Cytochalasin B: inhibition of D-2-deoxyglucose transport into leukocytes and fibroblasts. Science (1972) 1.85
Polymorphonuclear leukocyte adherence induces actin polymerization by a transduction pathway which differs from that used by chemoattractants. J Cell Biol (1989) 1.73
Chemoattractant-stimulated polymorphonuclear leukocytes contain two populations of actin filaments that differ in their spatial distributions and relative stabilities. J Cell Biol (1990) 1.71
Cytoplasmic granule formation in myelocytes. An electron microscope radioautographic study on the mechanism of formation of cytoplasmic granules in rabbit heterophilic myelocytes. J Cell Biol (1966) 1.69
An actin-nucleating activity in polymorphonuclear leukocytes is modulated by chemotactic peptides. J Cell Biol (1986) 1.67
Clinicotopographical correlation of corticospinal tract stroke: a color-coded diffusion tensor imaging study. Stroke (2003) 1.61
Structure of monocytes and macrophages. Semin Hematol (1970) 1.59
A proposal for the definition of terms related to locomotion of leucocytes and other cells. Clin Exp Immunol (1977) 1.55
Organization of myosin in a submembranous sheath in well-spread human fibroblasts. Exp Cell Res (1979) 1.53
Asymmetric distribution of the chemotactic peptide receptor on polymorphonuclear leukocytes. J Cell Biol (1984) 1.52
Failure to demonstrate peri-infarct depolarizations by repetitive MR diffusion imaging in acute human stroke. Stroke (2000) 1.47
Kinetic analysis of chemotactic peptide receptor modulation. J Cell Biol (1982) 1.45
Chemotropism indices for polymorphonuclear leukocytes. Biophys J (1976) 1.40
Actin filament barbed-end capping activity in neutrophil lysates: the role of capping protein-beta 2. Mol Biol Cell (1995) 1.38
Actin polymerization: Where the WASP stings. Curr Biol (1999) 1.35
Studies on attachment and ingestion phases of phagocytosis of Mycoplasma pulmonis by mouse peritoneal macrophages. Proc Soc Exp Biol Med (1972) 1.33
Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes. J Cell Biol (1992) 1.33
Consequences of chemotactic peptide receptor modulation for leukocyte orientation. J Cell Biol (1981) 1.32
Macrophage plasma membranes. I. Isolation and studies on protein components. J Exp Med (1971) 1.32
Acute and chronic changes of the apparent diffusion coefficient in neurological disorders--biophysical mechanisms and possible underlying histopathology. J Neurol Sci (2001) 1.28
Focusing on unpolymerized actin. J Cell Biol (1993) 1.24
Lysozyme: its absence in tears and leukocytes of cattle. Aust J Exp Biol Med Sci (1967) 1.24
Profilin enhances Cdc42-induced nucleation of actin polymerization. J Cell Biol (2000) 1.21
Restoration of antibody-forming capacity in cultures of nonadherent spleen cells by mercaptoethanol. Science (1972) 1.19
Suicide and violence prevention: parent education in the emergency department. J Am Acad Child Adolesc Psychiatry (1999) 1.19
Chemoattractant stimulation of polymorphonuclear leucocyte locomotion. Semin Cell Biol (1990) 1.12
Studies on isolated membranes of azurophil and specific granules from rabbit polymorphonuclear leukocytes. J Cell Biol (1972) 1.09
Chemotactic factor concentration gradients in chemotaxis assay systems. J Immunol Methods (1981) 1.08
Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum. I. Morphologic aspects. Exp Cell Res (1971) 1.08
Macrophage plasma membrane. II. Studies on synthesis and turnover of protein constituents. J Exp Med (1971) 1.08
Orientation chamber in chemotaxis. Methods Enzymol (1988) 1.07
Chemoattractant-stimulated GTPase activity is decreased on membranes from polymorphonuclear leukocytes incubated in chemoattractant. J Biol Chem (1989) 1.06
Mechanisms responsible for F-actin stabilization after lysis of polymorphonuclear leukocytes. J Cell Biol (1992) 1.03
Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum. II. Kinetic features and metabolic requirements. Exp Cell Res (1971) 1.02
Characterization of tetramethylrhodaminyl-phalloidin binding to cellular F-actin. Cell Motil Cytoskeleton (1992) 0.99
Measurement of the chemotaxis coefficient for human neutrophils in the under-agarose migration assay. Cell Motil Cytoskeleton (1988) 0.99
Measurement of leukocyte motility and chemotaxis parameters with a linear under-agarose migration assay. J Immunol (1983) 0.99
A proposal for the definition of terms related to locomotion of leukocytes and other cells. J Immunol (1977) 0.97
Distribution of F-actin elongation sites in lysed polymorphonuclear leukocytes parallels the distribution of endogenous F-actin. Cell Motil Cytoskeleton (1993) 0.96
Cdc42-induced actin filaments are protected from capping protein. Curr Biol (1999) 0.95
[Mononuclear phagocytic system: new classification of macrophages, monocytes and of their cell line]. Bull World Health Organ (1972) 0.94
Measurement of leukocyte motility and chemotaxis parameters with the Millipore filter assay. J Immunol Methods (1989) 0.93
Appearance and distribution of ferritin in mouse peritoneal macrophages in vitro after uptake of heterologous erythrocytes. J Cell Biol (1973) 0.92
Induction of actin polymerization in permeabilized neutrophils. Role of ATP. J Biol Chem (1994) 0.91
Assays of leukocyte chemotaxis. Annu Rev Med (1986) 0.90
Chemotactic peptide binding by rabbit polymorphonuclear leukocytes. Presence of two compartments having similar affinities but different kinetics. J Biol Chem (1986) 0.90
Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis. Neuroimage (2008) 0.89
Binding of IgG containing immune complexes to human neutrophil Fc gamma RII and Fc gamma RIII induces actin polymerization by a pertussis toxin-insensitive transduction pathway. J Immunol (1991) 0.88
A modified millipore filter method for assaying polymorphonuclear leukocyte locomotion and chemotaxis. Antibiot Chemother (1971) (1974) 0.88
Actin polymerization induced by GTP gamma S in permeabilized neutrophils is induced and maintained by free barbed ends. J Biol Chem (1995) 0.85
Orientation of PMN in a pH gradient: acid-induced release of a chemotactic factor. J Immunol (1981) 0.84
A proposal for the definition of terms related to locomotion of leucocytes and other cells. Cell Biol Int Rep (1977) 0.84
Copper on intrauterine devices stimulates leukocyte exudation. Science (1972) 0.83
Concentration gradients of chemotactic factors in chemotaxis assays. Methods Enzymol (1988) 0.83
Nucleolar fragmentation in L cells exposed to quinacrine in vitro. Cancer Res (1969) 0.82
Phosphorylase a activity as an indicator of neutrophil activation by chemotactic peptide. J Cell Biol (1985) 0.81
CRYSTALLOID STRUCTURE IN GRANULES OF GUINEA PIG BASOPHILS AND HUMAN MAST CELLS. J Cell Biol (1965) 0.81
The greatest success story in the history of medicine. Med Times (1980) 0.79
A possible role for granulocytes in the action of intrauterine contraceptive devices. Trans Assoc Am Physicians (1967) 0.79
Measurement of chemoattractant concentration profiles and diffusion coefficient in agarose. J Immunol Methods (1984) 0.78
Glycogen phosphorylase: a noninvasive indicator of cytoplasmic calcium. Methods Enzymol (1987) 0.77
Physiopathologic responses of the rhesus monkey to live Escherichia coli. Surg Gynecol Obstet (1976) 0.77
Polymorphonuclear leucocyte chemotaxis: detection of the gradient and development of cell polarity. Ciba Found Symp (1980) 0.77
Effects of sodium on chemotactic peptide binding to polymorphonuclear leukocytes. J Immunol (1985) 0.77
A method for movement. Nat Cell Biol (1999) 0.75